Open AccessCan Alpha-1 Antitrypsin Levels be Used to Predict the Prognosis of COVID-19 Therapy?
Author(s) -
Elif Aras Atik,
Nesligül Özdemir,
Kutay Demirkan
Publication year - 2020
Publication title -
turkish journal of pharmaceutical sciences
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.241
H-Index - 14
eISSN - 2148-6247
pISSN - 1304-530X
DOI - 10.4274/tjps.galenos.2020.20727
Subject(s) - covid-19 , alpha (finance) , medicine , rescue therapy , virology , intensive care medicine , disease , infectious disease (medical specialty) , outbreak , clinical psychology , construct validity , psychometrics
©Turk J Pharm Sci, Published by Galenos Publishing House. *Correspondence: E-mail: eczelifaras@gmail.com, Phone: +90 537 789 31 89 ORCID-ID: orcid.org/0000-0001-8667-6623 Received: 31.08.2020, Accepted: 13.09.2020 Anahtar kelimeler: COVID-19, alfa-1 antitripsin, tedavi
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom